Cardinal Health Past Earnings Performance
Past criteria checks 5/6
Cardinal Health has been growing earnings at an average annual rate of 47.8%, while the Healthcare industry saw earnings growing at 5.7% annually. Revenues have been growing at an average rate of 9.4% per year.
Key information
47.8%
Earnings growth rate
48.5%
EPS growth rate
Healthcare Industry Growth | 8.5% |
Revenue growth rate | 9.4% |
Return on equity | n/a |
Net Margin | 0.6% |
Last Earnings Update | 31 Dec 2024 |
Recent past performance updates
Recent updates
Cardinal Health: Demand For Medical Supplies To Grow, But Negative Equity Persists
Jan 09Here's Why We Think Cardinal Health (NYSE:CAH) Might Deserve Your Attention Today
Jan 03Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.5056
Dec 07Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.5056
Nov 23Cardinal Health (NYSE:CAH) Has Affirmed Its Dividend Of $0.5056
Nov 09Results: Cardinal Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Nov 05Cardinal Health Q1 Earnings: Margins Signal More Upside
Nov 04Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.5056
Sep 24Here's Why We Think Cardinal Health (NYSE:CAH) Is Well Worth Watching
Sep 17Cardinal Health (NYSE:CAH) Is Due To Pay A Dividend Of $0.5056
Aug 19Cardinal Health: Growth Headwinds Ahead
Aug 01Cardinal Health: Growing Into The Valuation
Jul 02Cardinal Health (NYSE:CAH) Has Announced That It Will Be Increasing Its Dividend To $0.5056
Jun 11Cardinal Health's Valuation Makes The Name Unattractive
May 26Cardinal Health Q3 Earnings: Undervalued On Strong Guidance
May 03Potential Upside For Cardinal Health, Inc. (NYSE:CAH) Not Without Risk
Apr 14Is Cardinal Health, Inc. (NYSE:CAH) Trading At A 50% Discount?
Mar 09Cardinal Health: Continued Business Growth And Huge Medical Supplies Market Penetration
Feb 20Cardinal Health, Inc. (NYSE:CAH) Just Released Its Second-Quarter Earnings: Here's What Analysts Think
Feb 03Cardinal Health Is Setting Up For A Great 2024
Dec 21Cardinal Health: A Revenue Growth Gem Plagued By Symptoms Of Negative Equity
Oct 13Cardinal Health: Better EPS Growth Clarity, Buying Back Shares, A Buy On Valuation
Aug 07Cardinal Health: Not A Long-Term Investment
May 24Cardinal Health: Downgrading Due To Absence Of Safety Margin (Rating Downgrade)
Feb 21Cardinal Health declares $0.4957 dividend
Feb 10Cardinal Health FQ2 2023 Earnings Preview
Feb 01Cardinal Health partners with Palantir for data-driven supply chain support
Jan 26Cardinal Health Is A Tempting Healthcare Income Play
Dec 28Revenue & Expenses Breakdown
How Cardinal Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 24 | 222,276 | 1,312 | 5,129 | 0 |
30 Sep 24 | 224,454 | 1,280 | 5,091 | 0 |
30 Jun 24 | 226,827 | 852 | 5,000 | 0 |
31 Mar 24 | 220,426 | 604 | 4,984 | 0 |
31 Dec 23 | 216,002 | 691 | 4,881 | 0 |
30 Sep 23 | 210,026 | 208 | 4,789 | 0 |
30 Jun 23 | 204,979 | 330 | 4,800 | 0 |
31 Mar 23 | 198,662 | 463 | 4,722 | 0 |
31 Dec 22 | 193,011 | -1,273 | 4,680 | 0 |
30 Sep 22 | 186,999 | -1,094 | 4,640 | 0 |
30 Jun 22 | 181,326 | -938 | 4,512 | 0 |
31 Mar 22 | 176,847 | -955 | 4,531 | 0 |
31 Dec 21 | 171,286 | 555 | 4,514 | 0 |
30 Sep 21 | 167,370 | 1,135 | 4,510 | 0 |
30 Jun 21 | 162,467 | 611 | 4,533 | 0 |
31 Mar 21 | 156,570 | 1,151 | 4,541 | 0 |
31 Dec 20 | 156,452 | 1,382 | 4,586 | 0 |
30 Sep 20 | 154,646 | 973 | 4,602 | 0 |
30 Jun 20 | 152,922 | -3,696 | 4,572 | 0 |
31 Mar 20 | 153,586 | -4,158 | 4,600 | 0 |
31 Dec 19 | 149,657 | -4,212 | 4,531 | 0 |
30 Sep 19 | 147,662 | -4,152 | 4,432 | 0 |
30 Jun 19 | 145,534 | 1,363 | 4,480 | 0 |
31 Mar 19 | 143,530 | 3 | 4,586 | 0 |
31 Dec 18 | 141,935 | -39 | 4,622 | 0 |
30 Sep 18 | 139,381 | 734 | 4,689 | 0 |
30 Jun 18 | 136,809 | 256 | 4,596 | 0 |
31 Mar 18 | 134,426 | 1,696 | 4,308 | 0 |
31 Dec 17 | 132,614 | 1,823 | 4,137 | 0 |
30 Sep 17 | 130,578 | 1,094 | 3,917 | 0 |
30 Jun 17 | 129,976 | 1,288 | 3,775 | 0 |
31 Mar 17 | 128,394 | 1,346 | 3,762 | 0 |
31 Dec 16 | 127,236 | 1,351 | 3,715 | 0 |
30 Sep 16 | 125,530 | 1,353 | 3,726 | 0 |
30 Jun 16 | 121,546 | 1,427 | 3,648 | 0 |
31 Mar 16 | 117,710 | 1,387 | 3,525 | 0 |
31 Dec 15 | 112,423 | 1,366 | 3,414 | 0 |
30 Sep 15 | 106,516 | 1,329 | 3,307 | 0 |
30 Jun 15 | 102,531 | 1,212 | 3,240 | 0 |
31 Mar 15 | 97,877 | 1,154 | 3,188 | 0 |
31 Dec 14 | 93,928 | 1,104 | 3,121 | 0 |
30 Sep 14 | 90,631 | 1,089 | 3,071 | 0 |
30 Jun 14 | 91,084 | 1,163 | 3,028 | 0 |
31 Mar 14 | 93,610 | 343 | 3,009 | 0 |
Quality Earnings: CAH has high quality earnings.
Growing Profit Margin: CAH's current net profit margins (0.6%) are higher than last year (0.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CAH has become profitable over the past 5 years, growing earnings by 47.8% per year.
Accelerating Growth: CAH's earnings growth over the past year (89.9%) exceeds its 5-year average (47.8% per year).
Earnings vs Industry: CAH earnings growth over the past year (89.9%) exceeded the Healthcare industry 10.2%.
Return on Equity
High ROE: CAH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/30 05:08 |
End of Day Share Price | 2025/01/30 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cardinal Health, Inc. is covered by 40 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
David Toung | Argus Research Company |
Gregory Bolan | Avondale Partners |
Eric Coldwell | Baird |